In human lung adenocarcinomas, increased expression of both p-eIF2α and ATF4 is mainly observed in advanced tumor subtypes with aggressive growth patterns, high risk of recurrence, and poor prognosis [22,23]. Here, ATF4 is linked to lung adenocarcinoma.